124 related articles for article (PubMed ID: 37633047)
41. The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition.
Xia Q; Cai Y; Peng R; Wu G; Shi Y; Jiang W
Int J Oncol; 2014 Mar; 44(3):735-44. PubMed ID: 24378347
[TBL] [Abstract][Full Text] [Related]
42. Protein expression of DNA damage repair proteins dictates response to topoisomerase and PARP inhibitors in triple-negative breast cancer.
Boerner JL; Nechiporchik N; Mueller KL; Polin L; Heilbrun L; Boerner SA; Zoratti GL; Stark K; LoRusso PM; Burger A
PLoS One; 2015; 10(3):e0119614. PubMed ID: 25774912
[TBL] [Abstract][Full Text] [Related]
43. RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy.
Wiegmans AP; Miranda M; Wen SW; Al-Ejeh F; Möller A
Oncotarget; 2016 Sep; 7(37):60087-60100. PubMed ID: 27507046
[TBL] [Abstract][Full Text] [Related]
44. MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability.
Choi YE; Pan Y; Park E; Konstantinopoulos P; De S; D'Andrea A; Chowdhury D
Elife; 2014 Apr; 3():e02445. PubMed ID: 24843000
[TBL] [Abstract][Full Text] [Related]
45. Rad51 recruitment and exclusion of non-homologous end joining during homologous recombination at a Tus/Ter mammalian replication fork barrier.
Willis NA; Panday A; Duffey EE; Scully R
PLoS Genet; 2018 Jul; 14(7):e1007486. PubMed ID: 30024881
[TBL] [Abstract][Full Text] [Related]
46. A Short BRCA2-Derived Cell-Penetrating Peptide Targets RAD51 Function and Confers Hypersensitivity toward PARP Inhibition.
Trenner A; Godau J; Sartori AA
Mol Cancer Ther; 2018 Jul; 17(7):1392-1404. PubMed ID: 29654063
[TBL] [Abstract][Full Text] [Related]
47. Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair.
Ceccaldi R; Liu JC; Amunugama R; Hajdu I; Primack B; Petalcorin MI; O'Connor KW; Konstantinopoulos PA; Elledge SJ; Boulton SJ; Yusufzai T; D'Andrea AD
Nature; 2015 Feb; 518(7538):258-62. PubMed ID: 25642963
[TBL] [Abstract][Full Text] [Related]
48. Suppression of homologous recombination sensitizes human tumor cells to IGF-1R inhibition.
Lodhia KA; Gao S; Aleksic T; Esashi F; Macaulay VM
Int J Cancer; 2015 Jun; 136(12):2961-6. PubMed ID: 25388513
[TBL] [Abstract][Full Text] [Related]
49. HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination.
Adimoolam S; Sirisawad M; Chen J; Thiemann P; Ford JM; Buggy JJ
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19482-7. PubMed ID: 18042714
[TBL] [Abstract][Full Text] [Related]
50. RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer.
Liu Y; Burness ML; Martin-Trevino R; Guy J; Bai S; Harouaka R; Brooks MD; Shang L; Fox A; Luther TK; Davis A; Baker TL; Colacino J; Clouthier SG; Shao ZM; Wicha MS; Liu S
Clin Cancer Res; 2017 Jan; 23(2):514-522. PubMed ID: 28034904
[TBL] [Abstract][Full Text] [Related]
51. RAD51-Mediated DNA Homologous Recombination Is Independent of
Sinha A; Saleh A; Endersby R; Yuan SH; Chokshi CR; Brown KR; Kuzio B; Kauppinen T; Singh SK; Baker SJ; McKinnon PJ; Katyal S
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33138032
[TBL] [Abstract][Full Text] [Related]
52. CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer.
Johnson SF; Cruz C; Greifenberg AK; Dust S; Stover DG; Chi D; Primack B; Cao S; Bernhardy AJ; Coulson R; Lazaro JB; Kochupurakkal B; Sun H; Unitt C; Moreau LA; Sarosiek KA; Scaltriti M; Juric D; Baselga J; Richardson AL; Rodig SJ; D'Andrea AD; Balmaña J; Johnson N; Geyer M; Serra V; Lim E; Shapiro GI
Cell Rep; 2016 Nov; 17(9):2367-2381. PubMed ID: 27880910
[TBL] [Abstract][Full Text] [Related]
53. Elp1 facilitates RAD51-mediated homologous recombination repair via translational regulation.
Chen WT; Tseng HY; Jiang CL; Lee CY; Chi P; Chen LY; Lo KY; Wang IC; Lin FJ
J Biomed Sci; 2021 Nov; 28(1):81. PubMed ID: 34819065
[TBL] [Abstract][Full Text] [Related]
54. Rad51 Silencing with siRNA Delivered by Porous Silicon-Based Microparticle Enhances the Anti-Cancer Effect of Doxorubicin in Triple-Negative Breast Cancer.
Wu Z; Zhu L; Mai J; Shen H; Xu R
J Biomed Nanotechnol; 2021 Dec; 17(12):2351-2363. PubMed ID: 34974858
[TBL] [Abstract][Full Text] [Related]
55. Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer.
Carey JPW; Karakas C; Bui T; Chen X; Vijayaraghavan S; Zhao Y; Wang J; Mikule K; Litton JK; Hunt KK; Keyomarsi K
Cancer Res; 2018 Feb; 78(3):742-757. PubMed ID: 29180466
[TBL] [Abstract][Full Text] [Related]
56. The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer.
Wilson AJ; Stubbs M; Liu P; Ruggeri B; Khabele D
Gynecol Oncol; 2018 Jun; 149(3):575-584. PubMed ID: 29567272
[TBL] [Abstract][Full Text] [Related]
57. MiR-34s negatively regulate homologous recombination through targeting RAD51.
Chen S; Liu R; Wang Q; Qi Z; Hu Y; Zhou P; Wang Z
Arch Biochem Biophys; 2019 May; 666():73-82. PubMed ID: 30951682
[TBL] [Abstract][Full Text] [Related]
58. Natural product β-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy.
Zhang L; Peng Y; Uray IP; Shen J; Wang L; Peng X; Brown PH; Tu W; Peng G
DNA Repair (Amst); 2017 Dec; 60():89-101. PubMed ID: 29112893
[TBL] [Abstract][Full Text] [Related]
59. Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway.
Sinha S; Chatterjee S; Paul S; Das B; Dash SR; Das C; Kundu CN
Exp Cell Res; 2022 Nov; 420(1):113338. PubMed ID: 36075449
[TBL] [Abstract][Full Text] [Related]
60. Akt1 Stimulates Homologous Recombination Repair of DNA Double-Strand Breaks in a Rad51-Dependent Manner.
Mueck K; Rebholz S; Harati MD; Rodemann HP; Toulany M
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]